Published in N Engl J Med on July 04, 1991
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A (1998) 5.48
High rate of antidepressant treatment in elderly people who commit suicide. BMJ (1996) 0.90
Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin Diagn Lab Immunol (1994) 0.83
Participating in the evolution of transfusion medicine from a dispensary into a discipline. Transfus Med Rev (2008) 0.78
Are worry-free transfusions just a whiff of ozone away? CMAJ (1993) 0.75
Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies. Biologicals (2011) 0.75
The risk of HIV-1 in screened blood donations. N Engl J Med (1991) 0.75
DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science (1988) 13.46
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell (1989) 9.66
Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol (1994) 6.76
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1989) 6.16
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol (1987) 5.27
Biology of hepatitis B virus. Science (1981) 4.93
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med (1989) 4.20
Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis (1988) 2.90
Direct detection of HIV RNA expression in seropositive subjects. Lancet (1988) 2.75
Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol (1991) 2.72
Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. Mol Cell Biol (1986) 2.69
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol (1999) 2.68
A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med (1989) 2.58
Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis (1988) 2.56
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med (1989) 2.44
Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34
HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA. Blood (1988) 2.30
Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med (1988) 2.25
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis (1994) 2.15
Prospective comparison of laparoscopic and conventional anterior resection. Br J Surg (1993) 2.15
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A (1997) 2.11
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis (1985) 2.10
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet (1988) 1.95
Detection of HIV-1 RNA sequences by in vitro DNA amplification. Nucleic Acids Res (1988) 1.90
Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis (1989) 1.88
Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol (1972) 1.83
Questionable efficacy of confidential unit exclusion. Transfusion (1990) 1.81
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A (1982) 1.81
The use of expired air to measure intestinal gas formation. Ann N Y Acad Sci (1968) 1.79
Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury. J Infect Dis (1995) 1.79
A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Res (1990) 1.76
Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science (1972) 1.72
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest (1990) 1.70
A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J Clin Microbiol (1997) 1.68
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses (1999) 1.66
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Immune response to hepatitis B surface antigen. Infect Immun (1975) 1.59
Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction. Anal Biochem (1990) 1.57
Arabidopsis cop8 and fus4 mutations define the same gene that encodes subunit 4 of the COP9 signalosome. Plant Cell (1999) 1.56
Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet (1983) 1.55
Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang (1967) 1.54
PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J Clin Microbiol (2000) 1.53
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51
Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity. Eur J Heart Fail (2015) 1.49
Dissociation of immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.49
Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil. Vox Sang (2006) 1.49
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol (1992) 1.48
Discrepancies in osmolal gaps and calculated alcohol concentrations. Arch Pathol Lab Med (1996) 1.46
The correlation of MLC with graft survival. Transplant Proc (1973) 1.44
Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42
HTLV-II-related disease. Lancet (1993) 1.40
Profile of prostatic-specific antigen in prostatic carcinomas. Mod Pathol (1993) 1.39
Correction of the hemostatic defects in Von Willebrand's disease. Blood (1967) 1.38
Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration. Transfusion (1989) 1.38
Determination of lactose intolerance by breath analysis. Am J Dig Dis (1969) 1.38
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med (2000) 1.37
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.36
A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer (1992) 1.33
Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol (1991) 1.32
Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol (1988) 1.32
The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies. Nucleic Acids Res (1997) 1.31
Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. Am J Pathol (1989) 1.31
Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30
Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr (1989) 1.28
Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology (1990) 1.28
Distinguishing between HTLV-I and HTLV-II by western blot. Lancet (1990) 1.27
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol (1990) 1.27
Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr (1995) 1.27
Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci U S A (1999) 1.27
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis (2000) 1.26
First-time blood donors: demographic trends. Transfusion (2001) 1.23